Apidel ^None

Apidel is a Swiss pharmaceutical company founded in 2011 that specializes in providing drug delivery solutions to create safer, more effective, and cost-efficient therapeutic products. The company's proprietary technologies allow for the formulation of effective drugs, new and established, into new pharmaceutical products with increased therapeutic potential. Apidel develops an internal pipeline of products utilizing approved pharmaceuticals and engages with pharmaceutical partners for joint development of products in various fields. By applying its technology to previously approved drug molecules, Apidel expects to accelerate the development and lower the clinical and regulatory risk of its product developments.